Study Results: MistGo® Sets a New Standard in Eye Care

The results are in! EYE-GO’s recent study involving 22 patients with glaucoma or high eye pressure over 14 days highlights the transformative impact of MistGo^® on eye medication delivery. Here’s what we learned:

Key findings:

1. Exceptional User-Friendliness: Patients rated MistGo^® 9.4/10 for ease of use, compared to 6.6/10 for traditional eye drops. “It was just…puff and done. Incredibly simple to use”

2. Superior Comfort: MistGo^® achieved a 9.5/10 comfort rating, surpassing traditional eye drops at 7.2/10. “There was no discomfort at all. Much more comfortable to eye drops”.

3. Minimal Waste, Maximum Precision: Patients reported being significantly less bothered by excess liquid, with MistGo^® scoring 9.9/10 vs 5.8/10 for traditional eye drops.

4. Overwhelming Preference: 20 of 22 participants indicated a preference for MistGo^® over traditional eye drops. “This will help a lot of people! When will it be on the market?”

What’s next?

EYE-GO is eager to bring these results to life. If you’re an investor or ophthalmology player passionate about transforming patient outcomes, let’s connect!